The Austrian Society for Allergology and Immunology is once again offering a prize of € 4000 for outstanding work in the field of basic immunological research for the year 2026. This prize is sponsored by the company Takeda. The submitter must be an ÖGAI member.
Due to the more and more interdisciplinary nature of scientific research (e.g. combination of wet-lab and bioinformatics approaches) and thus also the increased number of shared first-author publications in high-profile journals, the ÖGAI board has slightly adapted the submission criteria. For this prize, one first-author work per scientist can be submitted. If there a several co-first authors that meet the eligibility criteria, then co-authors are encouraged to submit their work jointly. The publication has to deal with molecular and/or cellular immunological/immunopathological topics. Papers from clinical immunology can be considered if they essentially deal with basic immunological questions. The work must have been published in a recognized scientific journal with a strict review system within the last 2 years and have been carried out entirely, or at least for the most part, at an Austrian research institution. This work may not have previously won an award or been submitted for an award elsewhere at the same time. Resubmissions are possible.
The submission deadline is June 30, 2026.
The work is to be sent to office@oegai.org as a complete pdf document with a reduced size including scanned, handwritten signed declarations of consent from the co-authors and a short CV. If a reviewer would like a printed copy, we may ask you to send us one by post.
Austrian Society for Allergology and Immunology
office
c/o Vienna Medical Academy
Alserstrasse 4
1090 Vienna
The ÖGAI board decides on the award of the prize after a strict review and ranking by independent international experts. The prize will not be shared (unless co-first authors submitted jointly, then the award and prize money would be shared). will be presented at the next Annual Meeting of the ÖGAI, 4-6 November 2026, Vienna, Austria.
